Precision Biosciences Cash Flow Statement (2018-2026) | DTIL

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
21.66M-11.55M-30.71M-27.20M-29.54M-8.26M-9.06M-11.11M-8.86M4.03M-2.85M-3.10M25.43M-19.77M-23.74M-21.14M-21.12M-20.00M12.93M-8.39M
Share-based Compensation (Quarter)
3.90M4.55M4.43M4.39M5.14M5.13M4.54M4.09M3.87M3.10M2.97M2.91M2.93M3.20M3.57M2.82M2.94M2.39M-7.89M1.55M
Gains from Investment Securities (Quarter)
0.33M9.62M-17.92M-0.01M1.30M13.81M-0.05M-0.01M12.52M0.45M-0.63M0.01M0.35M0.02M-0.18M-0.01M-0.03M0.00M-0.39M0.00M
Non-cash Items (Quarter)
44.30M36.30M4.84M43.20M40.40M34.70M0.18M29.60M25.50M20.20M0.22M13.60M15.00M16.70M0.25M9.70M
Cash from Operations (Quarter)
-31.34M-23.91M-23.68M-28.87M-24.22M29.19M-21.84M-31.46M-21.13M-23.09M-8.42M-18.98M-14.87M-5.91M-18.68M-19.05M-20.27M-15.27M-11.25M-11.94M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.30M0.31M1.17M0.29M0.30M-0.38M0.09M0.21M0.53M-0.43M0.05M0.28M-0.03M0.61M0.30M0.31M0.32M0.32M0.33M0.34M
Depreciation & Amortization (CF) (Quarter)
2.37M2.26M2.17M1.97M1.93M1.94M1.96M1.95M1.97M1.62M1.28M1.14M0.84M0.59M0.45M0.40M0.33M0.31M0.34M0.30M
Change in Working Capital
Change in Receivables (Quarter)
-18.77M-49.79M0.01M-0.03M-0.04M2.84M-2.59M-0.51M-0.18M-0.02M0.04M-0.23M-0.00M0.00M-0.00M4.00M
Change in Account Payables (Quarter)
-0.03M0.05M0.63M-0.37M-0.20M0.39M0.34M-0.56M0.12M-0.05M2.00M-2.10M0.12M-0.19M0.07M-0.11M0.20M0.22M-1.05M0.65M
Change in Accured Expenses (Quarter)
1.24M-0.07M2.40M-5.15M2.44M0.47M0.42M-4.52M1.03M0.39M2.38M-5.84M1.82M2.04M-0.16M-5.12M0.68M0.53M2.15M-1.80M
Other Working Capital Changes (Quarter)
5.48M-5.78M-3.49M-2.83M46.69M-6.65M-36.25M-0.49M0.17M-0.52M-0.21M-0.26M-0.05M1.45M-0.67M-0.03M-0.02M-0.54M-25.67M-0.36M
Investing Activities
Capital Expenditures (Quarter)
1.69M0.73M1.50M0.82M0.78M1.09M0.63M0.52M1.08M0.39M-0.03M0.09M0.03M0.04M0.10M0.06M0.00M0.02M0.02M
Sales of Property, Plant and Equipment (Quarter)
0.04M0.06M0.01M0.02M0.04M0.00M
Cash from Investing Activities (Quarter)
-1.69M-1.48M-1.50M-0.82M-0.78M-1.09M-0.63M-0.72M-1.06M7.56M0.04M-0.03M-0.03M-0.06M-0.10M-0.31M-0.01M0.02M-0.33M-0.11M
Financing Activities
Other financing activities (Quarter)
-34.99M34.99M0.91M1.03M0.66M
Cash from Financing Activities (Quarter)
13.51M11.92M8.38M2.25M92.92M-0.18M0.74M1.85M-0.03M2.83M40.09M0.70M3.73M5.92M10.69M5.30M1.66M77.52M0.74M
Additional items
Change in Cash (Quarter)
-19.52M-13.47M-16.81M-27.44M67.91M27.92M-22.48M-31.44M-20.34M-15.56M-5.55M21.09M-14.20M-2.24M-12.86M-8.68M-14.98M-13.59M65.94M-11.31M
Free Cash Flow (Quarter)
-33.03M-24.64M-25.19M-29.69M-25.00M28.10M-22.48M-31.98M-22.21M-23.48M-8.40M-19.07M-14.90M-5.95M-18.78M-19.12M-20.27M-15.27M-11.27M-11.96M
Net Cash Flow (Quarter)
-19.52M-13.47M-16.81M-27.44M67.91M27.92M-22.48M-31.44M-20.34M-15.56M-5.55M21.09M-14.20M-2.24M-12.86M-8.68M-14.98M-13.59M65.94M-11.31M